Short-course Out-patient Pulmonary Rehabilitation and COPD Exacerbations
Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 10, 2015
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
Objectives: Chronic obstructive pulmonary disease (COPD) is a disease with significant morbidity and incurs heavy utilization of healthcare resources. The direct cost of hospital admissions related to COPD is the single largest source of expenditure in the public hospital system. This study assessed whether a short course pulmonary rehabilitation programme with periodic reinforcement exercise training and phone call reminders would help to increase physical activity in COPD patients and also decrease readmissions for AECOPD.
Hypothesis: The above programme can reduce readmissions for AECOP...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with COPD exacerbations
- Exclusion Criteria:
- • 1. History of asthma, lung resection or other significant pulmonary disease like pulmonary fibrosis.
- • 2. Active infection like pulmonary tuberculosis
- • 3. Unable to complete assessment due to physical and/or cognitive impairment
- • 4. Completed a pulmonary rehabilitation program in the previous 24 months.
- • 5. Having short life expectancy like subjects with terminal malignancy or intractable heart failure
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shatin, N.T., Hong Kong
Patients applied
Trial Officials
Fanny WS Ko, MD
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials